Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients.

Lescaille, Géraldine

Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients. [electronic resource] - Bone Jan 2014 - 103-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1873-2763

10.1016/j.bone.2013.10.002 doi


Antibodies, Monoclonal, Humanized--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bevacizumab
Bisphosphonate-Associated Osteonecrosis of the Jaw--drug therapy
Diphosphonates--adverse effects
Female
Humans
Imidazoles--adverse effects
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasms--drug therapy
Risk Factors
Treatment Outcome
Zoledronic Acid